TPSB2 and Obesity: Contrary to our hypothesis, patients with obesity and low VAT-MC gene expression (below median expression of both TPSB2 and CMA1) were either not significantly different, or in some parameters trended to, or exhibited significantly worse clinical parameters (Table 1, Figure 2A).